Celularity (CELU) Inventory Average (2021 - 2025)
Celularity (CELU) posted quarterly Inventory Average of $3.0 million for Q4 2025, down 35.13% year-over-year from $4.7 million in Q4 2024, and down 57.72% quarter-over-quarter from $7.2 million in Q3 2025.
Celularity (CELU) Inventory Average (2021 - 2025) Analysis & Trends
Celularity (CELU) has reported Inventory Average for 5 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Inventory Average fell 35.13% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 35.13% YoY), while the FY2025 annual figure was $4.5 million, down 20.03% from the prior year.
- Inventory Average retreated to $3.0 million in Q4 2025 per CELU's latest filing, from $7.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $19.7 million in Q2 2022 and bottomed at $3.0 million in Q4 2025.
- Historically, Inventory Average has averaged $7.2 million across 5 years, with a median of $5.4 million in 2023.
- Annual changes were most pronounced in 2023 — Inventory Average tumbled 71.5% — and 2025, when it surged 172.31%.
- Celularity's Inventory Average stood at $7.6 million in 2021, then tumbled by 31.05% to $5.3 million in 2022, then grew by 1.33% to $5.3 million in 2023, then decreased by 12.3% to $4.7 million in 2024, then plunged by 35.13% to $3.0 million in 2025.
- Business Quant data shows CELU's Inventory Average at $3.0 million in Q4 2025, $7.2 million in Q3 2025, and $9.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | 6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 7.19 Mn |
| Jun 30, 2025 | 9.01 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 5.34 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 5.27 Mn |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 19.69 Mn |
| Mar 31, 2022 | 12.13 Mn |
| Dec 31, 2021 | 7.65 Mn |